[Federal Register: April 9, 2003 (Volume 68, Number 68)]
[Notices]
[Page 17405]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09ap03-84]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on November 13, 2002, Dade
Behring Inc., Route 896 Corporate Boulevard, Building 100, Attn: RA/QA,
P.O. Box 6101, Newark, Delaware, 19714, made application by letter to
the Drug Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Ecogonine (9180)........................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The firm plans to produce bulk products used for the manufacture or
reagents and drug calibrator/controls, DEA exempt products.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, DC 20537, Attention: Drug Operations Section, Domestic Drug
Unit (ODOD) and must be filed no later than 60 days from publication.
Dated: March 21, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-8581 Filed 4-8-03; 8:45 am]
BILLING CODE 4410-09-M